For a company that has been either a group leader or solidly above peer averages for quite some time, MetLife (NYSE:MET) doesn't get a lot of benefit of the doubt these days. Some of that can be tied to the weak rate environment as well as uncertainties as to how large insurance companies like MetLife will be regulated in the future. I believe investors are too worried about the negatives on this name and are underrating the growth potential of the company's overseas businesses and the value of its strategic shift toward more protection-oriented and less capital-intensive business. These shares could be as much as 25% undervalued today, making it a very worthwhile name to consider at these...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|